Intrinsic Value of S&P & Nasdaq Contact Us

HeartBeam, Inc. BEAT NASDAQ

NASDAQ Capital Marke • Healthcare • Medical - Healthcare Information Services • US • USD

SharesGrow Score
49/100
3/6 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
Analyst Price Target
$5.00
+316.7%

HeartBeam, Inc. (BEAT) has a consensus analyst rating of Buy, based on 13 analysts covering the stock. Of those, 9 recommend buying, 4 recommend holding, and 0 recommend selling.

The analyst consensus price target for BEAT is $5.00, representing a +316.7% upside from the current price of $1.2. Price targets range from a low of $4.00 to a high of $5.50.

Analyst Consensus — BEAT

Buy
Strong Buy
0
Buy
9
Hold
4
Sell
0
Strong Sell
0
13 analysts
Price Targets
Consensus$5.00
High$5.50
Low$4.00
Median$5.50
Last Month Avg-
Last Quarter Avg-
Last Year Avg$4.38
All-Time Count5
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message